2019 AWARD WINNERS

General Category

Adi J. Klil-Drori, Vicky Tagalakis

Direct Oral Anticoagulants in End-Stage Renal Disease 

From Dr Adi Klil-Drori (Figure 7), who prepared his Most Popular Award winning contribution in collaboration with his colleague Dr Vicky Tagalakis (Figure 8), and most interestingly, this contribution was originally prepared as part of a previous (2016) Young Investigator Award15: “I am remarkably indebted to Seminars in Thrombosis and Hemostasis for having had the opportunity to write our review Direct Oral Anticoagulants in End-Stage Renal Disease as part of a 2016 Young Investigator Award. It is particularly humbling to learn that the topic chosen for this review of primarily local interest has attracted enough attention in the field to be recognized with a Most Popular Article Award. The editors at Seminars should be commended for the open dialogue that allowed the choice of this topic for the review and the constructive expression of ideas throughout its writing and critique. I would also like to take the time and thank my mentor and co-author Dr. Vicky Tagalakis for her support and guidance through the years of our collaboration, to which this shared award is a silver lining. Finally, a shout-out to all the CanVECTOR folks, the Canadian VTE network that supported me by a fellowship grant.”

 

Steve Kitchen, Stefan Tiefenbacher, Robert Gosselin

Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement Therapies 

From Bob Gosselin (Figure 9), responding also on behalf of his co-authors Dr Stefan Tiefenbacher (Figure 10) and Dr Steve Kitchen (Figure 11): "It is humbling to be bestowed the honor of an Eberhard Mammen Most Popular Article Award for our article entitled, “Factor Activity Assays for Monitoring Extended Half-Life FVIII and Factor IX Replacement Therapies.”  On a personal note, I remember Dr Mammen fondly, he was such a gregarious man with a passion to teach, especially laboratory technologists, which thus adds weighted value in receiving this award.  I thoroughly enjoyed the time we shared together and our collaboration on the PFA-100 project, which was eventually also published in this journal. My co-authors, Stefan Tiefenbacher and Steve Kitchen, should be acknowledged as providing the yeoman’s work on the latest award winning paper.  This honor affirms our desired goal of enlightening our clinical and laboratory colleagues about the rapidly changing field of hemophilia replacement therapy.  These new replacement therapies require more diligence on the part of the laboratory and technologist to provide accurate assessment of these extended half-life factor replacement drugs.  In addition, we would like to thank the editors of Seminars in Thrombosis and Hemostasis for identifying the need for an edition of the journal dedicated to laboratory testing in the arena of anticoagulation and replacement therapy. Lastly, I would like to thank Dr Dorothy Adcock, who shared the guest editor responsibilities with me on this issue of STH devoted to laboratory medicine."

 

Open Access Category

Douglas B. Kell, Etheresia Pretorius

To What Extent Are the Terminal Stages of Sepsis, Septic Shock, Systemic Inflammatory Response Syndrome, and Multiple Organ Dysfunction Syndrome Actually Driven by a Prion/Amyloid Form of Fibrin? 

From Dr. Douglas Kell (Figure 2): “Science advances in many ways; occasionally this arises from the synthesis of disparate ideas that are not necessarily seen as the mainstream but that come from mainstream experiments. Typically, these originate from ‘outsiders’ who happen to enter a field anew. Our paper falls into this category. My scientific collaboration with the brilliant and far-sighted Resia Pretorius started via the internet and has since been extended via an inter-laboratory travel scheme funded by the UK BBSRC (Biotechnology and Biological Sciences Research Council). It led to this award-winning paper, and illustrates precisely the power and importance of multidisciplinary collaborations.  What is especially gratifying is that the STH community has taken our ideas seriously enough to have studied our Open Access article in detail, and will – in the normal way of science – now dream up good experiments that will develop or constrain our proposals, especially those relating to our own novel findings of amyloidogenic blood clotting. We are most grateful to STH and to its thoughtful Editor-in-Chief in assisting this paper through the review and editorial process.”

From Dr. Resia Pretorius (Figure 3): “This was truly the best news yet for 2019! I am truly humbled, together with my long-standing research collaborator, and dear friend, Douglas Kell, to receive this award.  I am most grateful to Seminars in Thrombosis and Hemostasis, and in particular the Editor-in-Chief, for his accommodating handling of the paper; it made the author experience really pleasant. Thank you to STH for allowing us to publish our new concepts and line of thought about the role of bacterial components in disease and inflammation.   The award will be spent wisely to further fund our laboratory research endeavours.” 

 

Cecilia Beatrice Chighizola, Maria Gabriella Raimondo, Pier Luigi Meroni

Management of Thrombotic Antiphospholipid Syndrome 

From Dr Pier Luigi Meroni (Figure 4), speaking also on behalf of his coauthors Drs Cecilia Chighizola (Figure 5) and Gabriella Raimondo (Figure 6): “I am honored to receive together with Drs Cecilia Chighizola and Gabriella Raimondo an Eberhard F. Mammen Most Popular Article Award for 2019, for an article we published last year. In spite of the fact that antiphospholipid syndrome (APS) has been a formal independent clinical entity for more than 20 years, the knowledge on its pathogenesis has increased enormously, emphasizing the close connection between the immune system and the coagulation cascade. At the same time, we have changed and are still changing our management of APS patients; so, any updating on APS treatment is welcome. Cecilia, Gabriella and I tried to report such a feeling in our review article and we are truly glad that the paper attracted a lot of attention within the scientific community. In this regard, we really appreciate that our article will now be given a ‘free access’ status, which will foster its further distribution. The editors of Seminars in Thrombosis and Hemostasis have to be complimented on their capacity to recognize this need is in line with the usual policy of the Journal. I would like also to thank the Guest Editor of the issue in which the paper was published for the invitation to contribute our review article, and the publisher for providing the award.”  

 

 

2018 AWARD WINNERS

General Category

Thomas Gremmel, Andrew L. Frelinger III, Alan D. Michelson

Platelet Physiology 

From Dr. Thomas Gremmel: “I am grateful and truly honored to receive an Eberhard F. Mammen Most Popular Article Award in 2018 as it reflects the great interest in our work. It is amazing that our review on Platelet Physiology has already attracted a lot of attention within the scientific community, and was read and cited by many distinguished colleagues. I would like to thank my coauthors Alan D. Michelson and Andrew L. Frelinger for their support in preparing the article, Anne-Mette Hvas for her invitation to contribute a review article, and the publisher for providing the award. The editors of Seminars in Thrombosis and Hemostasis have to be complimented on their continued selection of very relevant topics for respective issues of the Journal. As a source of excellent review articles in thrombosis and hemostasis research, this journal plays a pivotal role in the dissemination of knowledge in the field. In this regard, I am particularly pleased that our article will now be given a ‘free access’ status, which will foster its further distribution.”

 

Susan Mallett

Clinical Utility of Viscoelastic Tests of Coagulation (TEG/ROTEM) in Patients with Liver Disease and during Liver Transplantation 

From Dr. Susan Mallett: “I was both delighted and surprised to receive the news that my review article had won a 2018 Eberhard Mammen award for the ‘general’ category. It is indeed a great honor, and highlights the degree of interest this article has attracted within the scientific community. It is especially valuable to me personally; as for so many years, outside of the field of perioperative medicine in which I practice; there has only been limited interest in the enormous potential of viscoelastic tests to provide clinically relevant and individualized information about the hemostatic status. Over the last decade, there has been a paradigm shift in the way coagulation in liver disease is understood, with much new and exciting work demonstrating that hemostasis is finely, albeit precariously, ‘re-balanced’ in stable patients with liver disease due to the multiple and complex changes that occur in the hemostatic system. The many limitations and inadequacies of conventional coagulation tests in terms of assessing bleeding and thrombotic risk in patients with liver disease are now recognized. Future research using global viscoelastic tests will undoubtedly help elucidate some of these risks, and also give more relevant information that has the potential to eliminate many precautionary component transfusions that are completely unnecessary. As a consequence, clinical practice may be significantly altered for the better. I would very much like to thank Professors Ton Lisman and Hau Kwaan, who guest edited the issue on Hemostatic Dysfunction in Liver Diseases, for having given me the opportunity to write this review article for STH.”

 

Open-Access Category

Adam Cuker, Eline T. Luning Prak, Douglas B. Cines

Can Immune Thrombocytopenia Be Cured with Medical Therapy?

From Dr. Adam Cuker: “On behalf of my coauthors, I am truly humbled and delighted to receive not one but two Eberhard Mammen 2018 Most Popular Article Awards. As with novelists, poets, and playwrights, we in the biomedical community write in the hopes of reaching and illuminating our audience and perhaps of moving the needle in our chosen field, if ever-so-slightly, in the direction of progress. These awards are a vindication of our work. I am deeply grateful to Seminars in Thrombosis and Hemostasis and to its founding Editor-in-Chief, Eberhard Mammen, for providing a platform for me to reach my audience.”

 

Adam Cuker

Clinical and Laboratory Diagnosis of Heparin-Induced Thrombocytopenia: An Integrated Approach

From Dr. Adam Cuker: “On behalf of my coauthors, I am truly humbled and delighted to receive not one but two Eberhard Mammen 2018 Most Popular Article Awards. As with novelists, poets, and playwrights, we in the biomedical community write in the hopes of reaching and illuminating our audience and perhaps of moving the needle in our chosen field, if ever-so-slightly, in the direction of progress. These awards are a vindication of our work. I am deeply grateful to Seminars in Thrombosis and Hemostasis and to its founding Editor-in-Chief, Eberhard Mammen, for providing a platform for me to reach my audience.”

 

2017 AWARD WINNERS

General Category

Kochawan Boonyawat, Mark A. Crowther

Venous Thromboembolism Prophylaxis in Critically Ill Patients 

From Drs. Mark Crowther and Kochawan Boonyawat: “We would like to thank the publishers for the honor of receiving the ‘Eberhard F. Mammen’ Award. Receiving such an award is one of the rare ways that we, as authors, realize the impact that our work is having. Review articles are undervalued in the scientific community because they are perceived to be less rigorous than ‘original science.’ Such awards, however, remind us that for most clinicians it is summaries and overviews that guide their practice. Seminars in Thrombosis & Hemostasis has always been regarded as a leading journal for high quality reviews across the spectrum of thrombosis and hemostasis; thus, to receive this award is a rare honor given the outstanding authorship list that this journal is able to command. It is also a great pleasure to find a journal that has put in place such an award for authors fortunate to work in areas of high clinical and research interest—the journal is to be congratulated on making this effort which is almost, in my opinion, unique. We look forward to working with Seminars in Thrombosis & Hemostasis in the future and to provide further contributions to the literature in this area.”

 

Marcel Levi, Tom van der Poll

Coagulation in Patients with Severe Sepsis 

From Dr. Marcel Levi, also on behalf of his coauthor Dr. Tom van der Poll: “I am most honored that this article has attracted so much attention. It is, in particular, wonderful that an article building on the work of Eberhard F. Mammen, published in the journal for which he was the leading editor for many years, now awards a prize in his name. I am really very proud. It is always very good to learn that a review article is well received and read by many colleagues and I can only hope it has been helpful for practicing physicians and researchers in this field.”

 

Open-Access Category

Gary W. Moore

Recent Guidelines and Recommendations for Laboratory Detection of Lupus Anticoagulants

From Dr. Gary Moore: “I am truly honored to receive this award because it reflects a degree of interest from within our scientific community, which is both amazing and humbling. Writing the review was a labor of love, as lupus anticoagulant detection continues to fascinate, intrigue, and at times frustrate me. The relatively close publication of guidelines from three expert panels on how to detect these sometimes elusive antibodies was a fantastic opportunity to compare and contrast their recommendations, discuss some of the differences, and try to clarify some of the ambiguities. As a coauthor of two of the guidelines, I was in a good position to understand how different groups worked together to come to their sometimes similar/sometimes diverse conclusions, and hope I nonetheless managed to be informative and objective in my synopsis. One always hopes that a publication will touch many professional lives, and thus to win this award confirms this to be so.”

 

Theodore E. Warkentin

Heparin-Induced Thrombocytopenia in Critically Ill Patients

From Dr. Theodore (Ted) Warkentin: “I was delighted to receive the wonderful—and unexpected—news that this heparin-induced thrombocytopenia (HIT) paper was identified as one of the ‘most popular articles’. Indeed, I like to share this paper with our McMaster hematology residents, as its concluding 1-page Appendix summarizes a helpful diagnostic and treatment approach to HIT; and the paper also addresses some vexing diagnostic issues, such as how to distinguish DIC-associated ischemic limb injury from that caused by HIT. I also would like to thank Professor Marcel Levi (University of Amsterdam), the Guest Editor of the issue (‘Thrombosis and Hemostasis Issues in Critically Ill Patients’) in which the HIT paper appears, for inviting the paper, and for overseeing the entire volume.”

 

2016 AWARD WINNERS

General Category

Philippe de Moerloose, Alessandro Casini, Marguerite Neerman-Arbez

Congenital Fibrinogen Disorders: An Update

From Dr. Philippe de Moerloose: “I am very honored to receive one of the 2016 Most Popular Article Awards for a review on Congenital Fibrinogen Disorders, written with my co-authors and close colleagues Alessandro Casini and Marguerite Neerman-Arbez. In Geneva, we have been working for more than 15 years on the genetic basis and clinical consequences of fibrinogen deficiencies. The fundamental knowledge gained in this field during the past decade has been quite substantial and has translated into a better comprehension of our patient phenotypes with a more tailored approach to their treatment. We are very pleased to learn that a large number of STH readers appreciated our updated review.”



Sanjeev Sethi, Fernando C. Fervenza

Pathology of Renal Diseases Associated with Dysfunction of the Alternative Pathway of Complement: C3 Glomerulopathy and Atypical Hemolytic Uremic Syndrome (aHUS)

From Dr. Sanjeev Sethi: “It is indeed an honor to be selected for one of the 2016 Most Popular Article Awards. Understanding the pathology behind C3 glomerulopathy and atypical hemolytic uremic syndrome is the key to the correct diagnosis, evaluation, and management of these patients. Over the last few years great advances have been made in understanding the role of alternative pathway of complement in C3 glomerulopathy and atypical hemolytic uremic syndrome. With better elucidation of the pathophysiology, the next step is the development of new agents that can target the specific underlying abnormality or defect that cause C3 glomerulopathy and atypical hemolytic uremic syndrome. I am very glad that our review of the pathology of these disease entities was well received, and I would also like to sincerely thank my colleague, friend and coauthor, Dr. Fernando Fervenza, with whom I have had numerous great discussions and collaborations.”



Open-Access Category

Shannon M. Bates

D-Dimer Assays in Diagnosis and Management of Thrombotic and Bleeding Disorders

From Dr. Shannon Bates: “I was surprised and very pleased to hear that my article had been awarded one of 2016 Most Popular Article Awards. Although I enjoy the opportunity that writing a review article provides to thoughtfully examine and synthesize the available literature, I must admit that I often wonder whether the resulting manuscript is of benefit to readers or even noticed. I am delighted, therefore, to find out that readers have found my article useful. It is an honor to receive this award.”



Giuseppe Lippi, Emmanuel J. Favaloro, Tiziana Meschi, Camilla Mattiuzzi, Loris Borghi, Gianfranco Cervellin

E-Cigarettes and Cardiovascular Risk: Beyond Science and Mysticism

From Dr. Giuseppe Lippi: “I was really delighted to know that our article on ‘e-cigarettes and cardiovascular risk’ had won one of the Eberhard Mammen Seminars in Thrombosis & Hemostasis 2015 most popular article awards. The issues of the possible health hazard posed by E-cigarettes is as relevant now as ever, if one considers that approximately two thirds of national governments around the globe have established strict regulations for e-cigarettes as of 2015. Briefly, in 2014 the European Union established new regulations forbidding advertising, setting limits on maximum concentrations of nicotine, limiting volumes of liquid that can be sold, requiring child-proof and tamper-proof packaging and empowering regulators to take act should the regulations be violated. In April 2014 in Australia, a court decision has made it illegal to sell or supply electronic cigarettes in Western Australia, regardless of their appearance or nicotine content. In the US, with a lack of federal regulations, many states use local e-cigarette regulations, most commonly to prohibit sales to minors. It is also noteworthy that the US Food and Drug Administration (FDA) agency has recently established an on-line database (i.e., Adverse Event Reports for e-Cigarettes), aiming to collect voluntary reports of adverse events involving e-cigarettes from consumers, health professionals and members of the public. Health concerns were mostly related to the evidence of enhanced risk of cardiac arrhythmias, hypertension and cardiovascular events, which may be further magnified by other potential effects such as increased respiratory and flow respiratory resistance. We are therefore really pleased that this article has generated such huge interest around this very actual public health issue.”



2015 AWARD WINNERS

General Category

Victor Tapson

Thrombolytic Therapy for Acute Pulmonary Embolism

From Dr. Victor Tapson: “I was delighted to hear that my article ‘Thrombolytic therapy for acute pulmonary embolism’ had won an Eberhard Mammen Seminars in Thrombosis & Hemostasis 2015 most popular article award...Even 40 years after publication of Urokinase/Streptokinase Pulmonary Embolism (PE) Trials, the indications for systemic thrombolysis, particularly in submassive PE, remain cloudy. Although the largest study to date has indicated no clear mortality difference when thrombolytics are administered in submassive PE, a large meta-analysis subsequently suggested improved mortality in this group....Because of the acute nature of these patients, the dilemma of whether to proceed with thrombolysis remains of tremendous interest to clinicians. Dr. Eberhard Mammen went to medical school in Germany, intending to take over his father's family practice. Those of us in the field of venous thromboembolism are very fortunate that he ultimately became involved in research, in addition to medical education and clinical practice.”

James N. George, Roseleen Charania

Evaluation of Patients with Microangiopathic Hemolytic Anemia and Thrombocytopenia

From Dr. James N. George: “This project was part of Dr. Roseleen Charania's Hematology-Oncology fellowship effort. We have had a lot of experience with patients who were initially suspected to have thrombotic thrombocytopenic purpura (TTP) but subsequently were discovered to have another etiology for the microangiopathic hemolytic anemia and thrombocytopenia. There have been many different etiologies. Dr. Charania's goal was to describe how we evaluate these patients. She did a superb job organizing our experience and presenting the critical points for patient evaluations. This was a great clinical project for her. She and I both learned a lot.”

Open-Access Category

Elaine M. Hylek

Anticoagulation Therapy for Atrial Fibrillation

From Dr. Elaine M. Hylek: “When I learned that I had received this award, I could not believe it. It is a true honor, especially coming from this community. The world of thrombosis has grown increasingly complex from basic mechanisms and treatments to the varied clinical settings and high-risk patients. Understanding the risks and benefits and helping our patients and colleagues make the most informed decisions was the overarching aim of this article.”

Cristhiam Rojas-Hernandez, David Garcia

The Novel Oral Anticoagulants

Dr. David Garcia provided the following commentary: “I am honored to receive one of the Eberhard Mammen Seminars in Thrombosis & Hemostasis 2015 Most Popular Article Awards. In my position, I am often asked to write review papers and I do occasionally wonder how many people benefit from the effort it takes to complete such a manuscript. In this case, I had the help of a superb colleague, Dr. Cristhiam Rojas-Hernandez (now a member of the Section of Benign Hematology at MD Anderson Cancer Center). We were fortunate to be invited to write this paper at a moment when there was a great deal of recently published, clinically actionable information available about the direct oral anticoagulants (DOACs), and I am very pleased to know that many Seminars readers found our synthesis of the evidence to be useful.”

2014 AWARD WINNERS

General Category

Kent Chapman, Michael Seldon, Ross Richards

Thrombotic Microangiopathies, Thrombotic Thrombocytopenic Purpura, and ADAMTS-13

Kent Chapman in response to his win: “As a scientist who performs ADAMTS-13 [a disintegrin and metalloproteinase with a thrombospondin type 1 motif, member 13] assays in the laboratory, I came to write this paper not only out of personal interest in the subject matter, but also as a part of the Master's degree I was enrolled in at the time. I also felt that the literature at the time regarding TTP [Thrombotic Thrombocytopenic Purpura] was lacking a comprehensive review of TMA [Thrombotic Microangiopathies], TTP, and ADAMTS-13 and it was my aim to try and collate all this information in one paper to help others with the understanding of a very complex and often misunderstood disease. I am delighted to receive this award and even more excited to realise that the paper has been as popular as it is.”

Dr. Chapman

Gili Kenet, Sofia Aronis, Yackov Berkun, Mariana Bonduel, Anthony Chan, Neil A. Goldenberg, Susanne Holzhauer, Alfonso Iorio, Janna Journeycake, Ralf Junker, Christoph Male, Marilyn Manco-Johnson, Patti Massicotte, Rolf Mesters, Paul Monagle, Heleen van Ommen, Leslie Rafini, Paolo Simioni, Guy Young, Ulrike Nowak-Göttl

Impact of Persistent Antiphospholipid Antibodies on Risk of Incident Symptomatic Thromboembolism in Children: A Systematic Review and Meta-Analysis

Drs. Gili Kenet and Ulrike Nowak-Göttl commenting their win: “Because thromboses and stroke in pediatric patients are rare diseases, conducting scientific studies within a single hospital or even within a single country is difficult. Aiming to gather scientific data and create recommendations that can be applied to a broad spectrum of children over the world we gathered together a large group of collaborators. We have previously chaired the pediatric/perinatal hemostasis scientific standardisation committee (SCC) of the International Society on Thrombosis and Haemostasis (ISTH), promoting international research collaboration and cooperative multicenter studies.”

Drs. Kenet and Nowak-Goettl

Open-Access Category

Birgitta Salmela, Lotta Joutsi-Korhonen, Elina Armstrong, Riitta Lassila

Active Online Assessment of Patients Using New Oral Anticoagulants: Bleeding Risk, Compliance, and Coagulation Analysis

From Birgitta Salmela and Riitta Lassila: “The 2014 Eberhard F. Mammen ‘Most Popular' articles award both surprised and delighted our team… Winning this award encourages us to continue to be active in improving patient care, collaborate with our colleagues and to follow the field of new and developing anticoagulants. We are honored to be acknowledged in this way and look forward to reading the excellent articles appearing in Seminars in Thrombosis & Hemostasis in the future.”

Drs. Salmela, Joutsi-Korhonen, Armstrong, and Lassila

2013 AWARD WINNERS

Cristiano Fava, Martina Montagnana, Emmanuel J. Favaloro, Gian Cesare Guidi, Giuseppe Lippi

Obstructive Sleep Apnea Syndrome and Cardiovascular Diseases

Obstructive sleep apnea syndrome (OSAS) is a chronic disease characterized by recurrent episodes of partial or complete upper airway collapse and obstruction during sleep, associated with intermittent oxygen desaturation, sleep fragmentation, and symptoms of disruptive snoring and daytime sleepiness. In this award winning article Fava et al. discuss the different aspects of the relationship between OSAS and pathogenically different conditions such as systemic hypertension, coronary artery disease, stroke, metabolic abnormalities, arrhythmias, and heart failure, and the authors also discuss the kaleidoscope of phenomena implicated in the pathogenesis of this challenging disease.

Dr. Fava

Antonella Tufano, Anna Guida, Matteo Nicola Dario Di Minno, Domenico Prisco, Anna Maria Cerbone, Giovanni Di Minno

Prevention of Venous Thromboembolism in Medical Patients with Thrombocytopenia or with Platelet Dysfunction: A Review of the Literature

Current guidelines for venous thromboembolism (VTE) primary prophylaxis are based on randomized clinical trials that exclude subjects at a potentially high bleeding risk. Thus no specific recommendation/algorithm for pharmacological prophylaxis in patients with thrombocytopenia and/or platelet dysfunction is available. In this article Tufano et al. provide information on this issue to optimize patients’ VTE prophylaxis.

Dr. Tufano

2012 Award Winners

Giuseppe Lippi, Massimo Franchini, Emmanuel J. Favaloro, Giovanni Targher
Moderate Red Wine Consumption and Cardiovascular Disease Risk: Beyond the “French Paradox”

This article was listed as the top downloaded article of this journal for some 15 months over the past 2-year period, evidencing its enduring popularity. Perhaps the upbeat message of “moderate red wine consumption” having a positive effect on “cardiovascular disease risk” provided some of the momentum to its popularity. Dr. Lippi is an Associate Editor of, and a frequent contributor to, Seminars in Thrombosis & Hemostasis.

Lippi_2012

 

 
Dr. Rak about his article: “It is always exciting to trace the links between the key concepts, and revisit how independent research streams forced us to pay attention to microparticles in the context of malignancy. I suspect that subconsciously I also attempted to justify the meanderings of my own scientific journey and curiosity. I suspect that similarly minded readers may have enjoyed this aspect, but the reception probably reflects our heightened collective interest in vesiculation as a biological process.”

 

Rak_2012

 

2011 Award Winners

Magdalena Sobieraj-Teague, Martin O’Donnell and John Eikelboom
New Anticoagulants for Atrial Fibrillation

Dr Sobieraj-Teague wrote this top article with colleagues at McMaster University in Canada during a 2-year postgraduate fellowship. She has since returned to Australia where she is a staff hematologist at Flinders Medical Center in Adelaide.

2011_MPA

 

Guglielmo Mariani and Francesco Bernardi
Factor VII Deficiency

Dr Mariani and Dr Barnardi are longtime collaborators and co-authors on the topic of factor VII deficiency. Their award-winning article was written while they were respectively at the University of Aquila and the University of Ferrara, both in Italy.

 

2011_MPA_2

 

2010 Award Winners

Given the closeness in results for the second and third ranked articles from 2008-2009, the Editorial Board decided on three winners for the Most Popular Article Award in 2010.

 

Job Harenberg and Martin Wehling
Current and future prospects for anticoagulant therapy: inhibitors of factor Xa and factor IIa

Job Harenberg and Martin Wehling have collaborated for more than two years in the field of clinical and pharmacological research into thromboembolic diseases, and are based at Faculty of Medicine Mannheim at the University of Heidelberg, Germany. Dr Harenberg, the corresponding author for the paper, is a long-time contributor to Seminars in Thrombosis and Hemostasis. An old friend of Eberhard Mammen, Dr Harenberg was delighted to hear of his award.

Job Harenberg and Martin Wehling
Martin Wehling (left) and Job Harenberg (right) at an angiology
symposium in Kitzbühel, Austria

Margaret Prechel and Jeanine M. Walenga
The laboratory diagnosis and clinical management of patients with heparin-induced thrombocytopenia: an update

Margaret Prechel and Jeanine Walenga are colleagues working in the Departments of Thoracic and Cardiovascular Surgery and Pathology at the Loyola Medical Center in Maywood, Illinois, USA. They are co-directors of a reference clinical laboratory focused on heparin-induced thrombocytopenia (HIT).

Dr Walenga was the corresponding author on the winning article and was very pleased to hear news of their award from Dr Emmanuel J. Favaloro, the Editor in Chief of Seminars in Thrombosis and Hemostasis.

Prechel_Walenga
Margaret Prechel (left) and Jeanine Walenga (right) at the
Loyola University Medical Center in Maywood, Illinois, USA

Jawed Fareed, Debra A. Hoppensteadt, Daniel Fareed,
Muzaffer Demir, Rakesh Wahi, Melaine Clarke, Cafer Adiguzel, Rodger Bick

Survival of heparins, oral anticoagulants, and aspirin after the year 2010

The final award in 2010 is for an article by Jawed Fareed and an international group of colleagues working on anticoagulants. Dr Fareed is a long-standing author of Seminars in Thrombosis and Hemostasis, having contributed 115 articles to the journal. He too was greatly honored to receive notification of the award.

Dr Fareed and Dr Hoppensteadt work together at the Loyola University Medical Center. Their main area of research is the development of newer tests for the diagnosis of thrombosis and the objective elevation of newer drugs to treat thrombosis and cardiovascular disease.

sth_fareed
Jawed Fareed (left) and Debra Hoppensteadt (right) at the
Loyola University Medical Center in Maywood, Illinois, USA


 

2009 Award Winners

Bruno Girolami and Antonio Girolami
Heparin-Induced Thrombocytopenia: A Review

Antonio and Bruno Girolami are a father and son co-authorship team. Antonio first met Eberhard Mammen about 25 years ago at the Meeting of the American Society of Hematology, and met him several times thereafter at various international meetings. The invitation to write the article came from the Guest Editor for that issue of Seminars in Thrombosis and Hemostasis (Paolo Prandoni) in consultation with Eberhard.

Bruno and Antonio Girolami
Bruno Girolami (left) and Antonio Girolami (right) outside of
the Institute of Semeiotica Medica at Padua University.

Kerstin Jurk and Beate E. Kehrel
Platelets: Physiology and Biochemistry

The invitation for Beate Kehrel to write her article came personally from Eberhard while at an international meeting, and both Beate and her co-author (Kerstin Jurk) were very happy to hear the news that they had won this award. In Beate's own words "Both of us love platelets and feel that we need to make scientists and medical doctors more familiar with the cinderellas of the blood cells".

Dr Emmanuel J Favaloro, the Editor in Chief of Seminars in Thrombosis and Hemostasis, met up with both Beate Kehrel and Kerstin Jurk at the recent ISTH meeting in Boston, and they expressed a wish to contribute further articles for this journal in the near future.

sth_jurk_kehrel
Beate Kehrel, Emmanuel Favaloro and Kerstin Jurk (left to right)
at the 2009 ISTH meeting in Boston.

Learn more about the Eberhard F Mammen awards by selecting the following links:

Get NEWS!

Sign up and be the first to get exclusive offers, sales, events, and more!

Yes, I would like to receive email newsletters with the latest news and information on products and services from Thieme Medical Publishers, Inc and selected cooperation partners in medicine and science regularly (about once a week). I agree to the use and processing of my personal information for this purpose. I can opt out at any time by clicking the "unsubscribe" link at the end of each newsletter.

Further information about data processing and your corresponding rights.

*Required field; all other fields are voluntary. We only use this information to personally address you in your newsletter.

Product Search